Clinical Trial Update: The Clinical Safety of Levofloxacin 1.5% vs Topical Moxifloxacin 0.5% [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update comparing safety of levofloxacin 1.5% versus topical moxifloxacin 0.5% in postoperative endophthalmitis, encompassing Phase 1 and Phase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endophthalmitis
• Endophthalmitis Postoperative

Drugs mentioned

• Levofloxacin 1.5% (levofloxacin)
• Moxifloxacin 0.5% (moxifloxacin)

Snippet

Sponsor: National University of Malaysia | Conditions: Endophthalmitis Postoperative | Phase 1, Phase 2 | Status: UNKNOWN